RXRX — Recursion Pharmaceuticals, Inc. Class A | Setup 20-24 Jul 2026
RXRX
Recursion Pharmaceuticals, Inc. Class A
📅 Earnings · Aug 11, 2026 · in 17d
SCORE IQS Lite
23/100
Weekly Structure 15
Daily Momentum 2
Weekly Ichimoku 0
Daily CMF 0
Delta 6
IQS Lite components · score
IQS Lite analysis - AiTrading67.com · Recursion Pharmaceuticals, Inc. Class A (RXRX · ISIN US75629V1044)
Weekly Structure
At 15/30 structure is developing: moving averages only partly aligned, trend unconfirmed.
Daily Momentum
At 2/35 momentum is absent: flat or negative daily impulse, no acceleration.
Weekly Ichimoku
At 0/19 Ichimoku is fully bearish: price below the cloud, Tenkan and Kijun unsupportive.
Daily CMF
At 0/6 CMF shows outflows: capital leaving and selling pressure.
Delta
At 6/10 the week is slightly positive: close between 0% and +2%.
Concise reading of each axis score · sum = IQS Lite (0-100)
Executive View
Our view last week
Compressed phase (IQS 18) suggests accumulation awaiting breakout, yet weekly decline (-17%) and daily MACD weakness constrain near-term upside. Setup promising for entry on confirmed breakout, pending conviction.
This week's view by AiTrading67.com
The ticker remains in a compressed phase within the neutral zone, with weekly moving averages in bearish alignment and Ichimoku below the cloud. The compression of the IQS Lite offers breakout potential, yet confirmation from volumes is required. The current view privileges awaiting consolidation before new directional entries.
Chart · 12-month trend
Charts provided by TradingView